NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 39 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,504 | $1,248 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 301,057 | $249,877 | 0.00% |
| STATE STREET CORP | 122,556 | $101,721 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 609,651 | $506,010 | 0.00% |
| MORGAN STANLEY | 821,972 | $682,236 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 175 | $144 | 0.00% |
| BlackRock Inc. | 483,948 | $401,677 | 0.00% |
| Bank of New York Mellon Corp | 14,372 | $11,929 | 0.00% |
| Citadel Advisors | 4,700 | $3,901 | 0.00% |
| Citadel Advisors | 47,891 | $39,750 | 0.00% |
| Farther Finance Advisors, LLC | 1,000 | $830 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,200 | $11,786 | 0.00% |
| HighTower Advisors, LLC | 48,409 | $40,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 184,500 | $153,135 | 0.00% |
| JPMORGAN CHASE & CO | 223 | $185 | 0.00% |
| Truvestments Capital LLC | 925 | $768 | 0.00% |
| VANGUARD GROUP INC | 1,010,812 | $838,974 | 0.00% |
| BARCLAYS PLC | 163 | $0 | 0.00% |
| FEDERATED HERMES, INC. | 1,555 | $1,291 | 0.00% |
External links
This page lists NEOLEUKIN THERAPEUTICS INC's shareholders in Q2 2023. To view NEOLEUKIN THERAPEUTICS INC's shareholder history, click here.